Mettl3-Mediated N6-Methyladenosine Modification Mitigates Ganglion Cell Loss and Retinal Dysfunction in Retinal Ischemia-Reperfusion Injury by Inhibiting FoxO1-Mediated Autophagy.
Zhu Feiyan, Feng Jiazhen, Pan Yiji, Ouyang Lingyi, He Tao, Xing Yiqiao
Mettl3-mediated m6A modification protects against retinal ganglion cell loss and dysfunction in retinal ischemia-reperfusion injury by inhibiting FoxO1-mediated autophagy, offering a potential therapeutic target for glaucoma.